Impact of tissue atrophy on high-pass filtered MRI signal phase-based assessment in large-scale group-comparison studies: a simulation study

The assessment of abnormal accumulation of tissue iron in the basal ganglia nuclei and in white matter plaques using the gradient echo magnetic resonance signal phase has become a research focus in many neurodegenerative diseases such as multiple sclerosis or Parkinson’s disease. A common and natural approach is to calculate the mean high-pass-filtered phase of previously delineated brain structures. Unfortunately, the interpretation of such an analysis requires caution: in this paper we demonstrate that regional gray matter atrophy, which is concomitant with many neurodegenerative diseases, may itself directly result in a phase shift seemingly indicative of increased iron concentration even without any real change in the tissue iron concentration. Although this effect is relatively small results of large-scale group comparisons may be driven by anatomical changes rather than by changes of the iron concentration.

[1]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[2]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[3]  Y. Cheng,et al.  Susceptibility mapping as a means to visualize veins and quantify oxygen saturation , 2010, Journal of magnetic resonance imaging : JMRI.

[4]  Xenophon Papademetris,et al.  Rapid calculations of susceptibility-induced magnetostatic field perturbations for in vivo magnetic resonance , 2006, Physics in medicine and biology.

[5]  C. Moonen,et al.  A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of bulk susceptibility , 2003 .

[6]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[7]  W H Oldendorf,et al.  Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores , 1993, Magnetic resonance in medicine.

[8]  Xiaojun Xu,et al.  Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study , 2008, NeuroImage.

[9]  D. Noll,et al.  Homodyne detection in magnetic resonance imaging. , 1991, IEEE transactions on medical imaging.

[10]  R. Benedict,et al.  The thalamus and multiple sclerosis , 2013, Neurology.

[11]  Markus Barth,et al.  Filtered deconvolution of a simulated and an in vivo phase model of the human brain , 2010, Journal of magnetic resonance imaging : JMRI.

[12]  M. Dwyer,et al.  Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis , 2013, Multiple sclerosis.

[13]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[14]  Min Lou,et al.  Evaluation of Brain Iron Content Based on Magnetic Resonance Imaging (MRI): Comparison among Phase Value, R2* and Magnitude Signal Intensity , 2012, PloS one.

[15]  Patrice Péran,et al.  Voxel‐based analysis of R2* maps in the healthy human brain , 2007, Journal of magnetic resonance imaging : JMRI.

[16]  Carlo Ciulla,et al.  Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain , 2007, Journal of magnetic resonance imaging : JMRI.

[17]  M. Ferrari,et al.  7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  M. Dwyer,et al.  Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy , 2012, American Journal of Neuroradiology.

[19]  Robert Zivadinov,et al.  Brain iron accumulation in aging and neurodegenerative disorders , 2012, Expert review of neurotherapeutics.

[20]  Robert Zivadinov,et al.  Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis A case-control study , 2012, NeuroImage.

[21]  P J Diaz,et al.  MR susceptometry: an external‐phantom method for measuring bulk susceptibility from field‐echo phase reconstruction maps , 1994, Journal of magnetic resonance imaging : JMRI.

[22]  Xiao-er Wei,et al.  An Investigation of Age-Related Iron Deposition Using Susceptibility Weighted Imaging , 2012, PloS one.

[23]  J. Reichenbach,et al.  Magnetic susceptibility-weighted MR phase imaging of the human brain. , 2005, AJNR. American journal of neuroradiology.

[24]  J R Reichenbach,et al.  Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.

[25]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.

[26]  Andreas Schäfer,et al.  Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI , 2009, NeuroImage.

[27]  Bing Wu,et al.  Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.

[28]  Ferdinand Schweser,et al.  Toward online reconstruction of quantitative susceptibility maps: Superfast dipole inversion , 2013, Magnetic resonance in medicine.

[29]  Yi Wang,et al.  Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI , 2009, Magnetic resonance in medicine.

[30]  Chunlei Liu,et al.  Whole brain susceptibility mapping using compressed sensing , 2012, Magnetic resonance in medicine.

[31]  J. Duyn,et al.  Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data , 2009, Magnetic resonance in medicine.

[32]  J. Reichenbach,et al.  Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. , 2010, Medical physics.

[33]  T. Luo,et al.  Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN). , 2012, European Journal of Radiology.

[34]  J R Reichenbach,et al.  High-Resolution MR Venography at 3.0 Tesla , 2000, Journal of computer assisted tomography.

[35]  Hisashi Tanaka,et al.  Determination of transverse relaxation rate for estimating iron deposits in central nervous system , 2005, Neuroscience Research.

[36]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain , 2012, NeuroImage.

[37]  Andrew J. Walsh,et al.  Susceptibility phase imaging with comparison to R2* mapping of iron-rich deep grey matter , 2011, NeuroImage.

[38]  Linda Douw,et al.  Subcortical atrophy and cognition , 2012, Neurology.

[39]  P D Griffiths,et al.  Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.

[40]  T. Luo,et al.  Iron deposition in the precentral grey matter in patients with multiple sclerosis: a quantitative study using susceptibility-weighted imaging. , 2013, European journal of radiology.

[41]  Pascal Spincemaille,et al.  Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping , 2013, Magnetic resonance in medicine.

[42]  Robert Turner,et al.  Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strength , 2013, NeuroImage.

[43]  R. Bowtell,et al.  Application of a Fourier‐based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility , 2005 .

[44]  Jeff H. Duyn,et al.  Susceptibility contrast in high field MRI of human brain as a function of tissue iron content , 2009, NeuroImage.

[45]  B. Drayer,et al.  Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? , 1987, AJR. American journal of roentgenology.

[46]  R. Bowtell,et al.  Susceptibility mapping in the human brain using threshold‐based k‐space division , 2010, Magnetic resonance in medicine.

[47]  Helen Nichol,et al.  Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X‐ray fluorescence , 2010, Journal of magnetic resonance imaging : JMRI.

[48]  R. Herfkens,et al.  Magnetic resonance imaging in multiple sclerosis: Decreased signal in thalamus and putamen , 1987, Annals of neurology.

[49]  J. R. Reichenbach,et al.  Effect of Age on MRI Phase Behavior in the Subcortical Deep Gray Matter of Healthy Individuals , 2013, American Journal of Neuroradiology.

[50]  Andrea Cherubini,et al.  Aging of subcortical nuclei: Microstructural, mineralization and atrophy modifications measured in vivo using MRI , 2009, NeuroImage.

[51]  A. Minagar,et al.  Gray matter SWI-filtered phase and atrophy are linked to disability in MS. , 2013, Frontiers in bioscience.

[52]  Yi Wang,et al.  A novel background field removal method for MRI using projection onto dipole fields (PDF) , 2011, NMR in biomedicine.

[53]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.